Zamtocabtagene autoleucel

DB18764InvestigationalCell transplant therapies

Zamtocabtagene autoleucel: Overview.

Mechanism: Pharmacologically active on B-lymphocyte antigen CD20 and B-lymphocyte antigen CD19
Curator reviewed
Code names: MB-CART2019.1

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zamtocabtagene autoleucel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.